Are financial payments from the pharmaceutical industry associated with physician prescribing? A systematic review

AP Mitchell, NU Trivedi, RL Gennarelli… - Annals of internal …, 2021 - acpjournals.org
Background: Financial payments from the drug industry to US physicians are common.
Payments may influence physicians' clinical decision making and drug prescribing. Purpose …

Making medicines affordable: a national imperative

SJ Nass, G Madhavan, NR Augustine - 2018 - books.google.com
Thanks to remarkable advances in modern health care attributable to science, engineering,
and medicine, it is now possible to cure or manage illnesses that were long deemed …

[HTML][HTML] Pharmaceutical company spending on research and development and promotion in Canada, 2013-2016: a cohort analysis

J Lexchin - Journal of pharmaceutical policy and practice, 2018 - Springer
Background Competing claims are made about the amount of money that pharmaceutical
companies spend on research and development (R&D) versus promotion. This study …

Physician characteristics, industry transfers, and pharmaceutical prescribing: empirical evidence from Medicare and the physician payment sunshine act

CS Brunt - Health Services Research, 2019 - Wiley Online Library
Objective To evaluate physician characteristics associated with pharmaceutical industry
transfers and prescribing behavior after public reporting under the Sunshine Act. Data …

[HTML][HTML] Pharmaceutical payments to Japanese board-certified infectious disease specialists: a four-year retrospective analysis of payments from 92 pharmaceutical …

A Murayama, S Kamamoto, H Saito, K Yamada… - International Journal of …, 2022 - mdpi.com
Backgrounds: Conflict of interest with pharmaceutical companies is one of the most
concerned issues in infectious diseases. However, there is a lack of whole picture of …

Association between drug characteristics and manufacturer spending on direct-to-consumer advertising

MJ DiStefano, JM Markell, CC Doherty, GC Alexander… - JAMA, 2023 - jamanetwork.com
Importance Some drugs are heavily marketed through direct-to-consumer advertising.
Objective To identify drug characteristics associated with a greater share of promotional …

Industry payments to physicians are kickbacks. How should stakeholders respond?

A Mitchell, A Sarpatwari… - Journal of Health Politics …, 2022 - read.dukeupress.edu
Payments from the pharmaceutical industry to US physicians are common. In determining
which payments rise to the level of an illegal kickback under the Anti-Kickback Statute (AKS) …

[HTML][HTML] Pharmaceutical pricing conundrum: time to get rid of it?

L Garattini, A Padula - The European Journal of Health Economics, 2018 - Springer
A basic concept of economics is that a price stems from the intersection between supply and
demand curves in any common market. However, there are markets where consumers do …

[HTML][HTML] Ensuring access to medicines: how to stimulate innovation to meet patients' needs?

D Panteli, S Edwards - 2018 - europepmc.org
The development of innovative medicines is essential for making progress in preventing and
treating diseases. However, the high price tags put on new medicines do not always reflect …

Increasing financial payments from industry to medical oncologists in the United States, 2014–2017

MW Rahman, NU Trivedi, PB Bach… - Journal of the National …, 2021 - jnccn.org
Background: Personal payments from the pharmaceutical industry to US physicians are
common and are associated with changes in physicians' clinical practice and interpretation …